All Stories

  1. Effectiveness of Distant/Remote Blessing Treatment on Cognitive-motor Function: A Randomized Double-blind Placebo-controlled Trial
  2. Exploring the Therapeutic Potentials of Nonpharmacological Blessing Energy Intervention for the Benefits of Psycho-Mental Impaired Individuals: A Clinical Trial
  3. Assessment of cognitive–motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non‐pharmacological intervention: A randomized double‐blind placebo controlled trial
  4. Effects of distant biofield energy healing on adults associated with psychological and mental health-related symptoms: a randomized, placebo-controlled, double-blind study
  5. The use of biofield energy therapy as complementary and alternative medicine in human health care system: a narrative review and potential mechanisms
  6. Quantum Biofield Energy Therapy for Psychological and Mental Health Problems
  7. Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines
  8. Vitamin D3 Supplementation: Improving Memory, Muscle Function, and Pain in Deficient Rats
  9. Simultaneous identification and quantification of pentacyclic triterpenoids and phenolic compounds from the leaves of Boswellia serrata using LC–MS/MS tandem mass spectrometry
  10. The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress‐related quality of life in adult subjects: A randomized controlled clinical trial
  11. Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
  12. Impact on Fundamental Physiological Functional Biomarkers after Administration of Biofield Treated Formulation in Unpredictable Chronic Stress (UCS)-Induced Rats
  13. Evaluation of Anti-inflammatory Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  14. Evaluation of Inflammatory Serum Cytokines after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley...
  15. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  16. Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  17. Evaluation of Antioxidative Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  18. Elasticity Profile of Skin, Neuronal, Cardiac, and Skeletal Muscle Cells after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation
  19. Oxidative Stress and Inflammatory Biomarkers Analysis of Biofield Treated Proprietary Test Formulation in Heart Tissues in Cecal Slurry, LPS and E. Coli-induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  20. Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  21. Evaluation of Immunomodulatory Effect of a Novel Test Formulation in D-Galactose-Induced Aging Dysfunction in Sprague Dawley Rats
  22. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Intestinal Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  23. Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  24. LC-MS and GC-MS-Based Assessment of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios of Sulfamethoxazole
  25. Structural Characterization and Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Ofloxacin
  26. Effect of Biofield Treatment on Blood, Hepatic, and Cardiac Biomarkers in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  27. Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
  28. Study of the Consciousness Energy Healing Treatment and It’s Effect on the Isotopic Abundance Ratio of Ascorbic Acid (Vitamin C)
  29. Evaluation of the Isotopic Abundance Ratio of Consciousness Energy Healing Treated L-Tryptophan Using LC-MS Spectrometry
  30. Effect of Consciousness Energy Healing Treatment on the Metal Profile and Properties of Tellurium
  31. Antioxidant Activity of Biofield Treated Proprietary Test Formulation Supplemented with Vitamins and Minerals in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  32. Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation a...
  33. Liquid Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated L-Cysteine
  34. "A Comprehensive Study of Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Berberine Chloride Using LC-MS and GC-MS"
  35. sotopic Abundance Ratio Evaluation of the Consciousness Energy Treated Pyridoxine Using LC-MS and GC-MS Spectrometry
  36. "Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid"
  37. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of L-Cysteine Using LC-MS Spectrometry
  38. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid Using LC-MS Spectrometry
  39. Influence of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  40. Impact of Biofield Energy Healing Treatment on the Isotopic Abundance Ratio Analysis of Pyridoxine HCl Using LC-MS and GC-MS Spectrometry
  41. Identification of Endothelin-1 and Nitric Oxide Activity in Aorta, Lung and Kidney after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-Name and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  42. Evaluation of Inflammatory Response after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  43. Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  44. Evaluation of Inflammatory Serum Biomarkers after Treatment with the Consciousness Energy Healing-Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  45. Study of VDR Expression after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation Using Cellular Models
  46. Estimation of Sex Hormone, Blood Profiling, and Histopathological Analysis after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)- Induced Sprague Dawley Rats
  47. Study of Behavioral Parameters in Vitamin D3 Deficiency Diet (VDD) Induced Animal Model: An Influence of Biofield Energy Healing Treatment
  48. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  49. The LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Silver Sulfadiazine
  50. Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
  51. Evaluation of Cardiac Biomarkers after Administration of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  52. Evaluation of Stress Biomakers (Cytokines) in Presence of Unpredictable Chronic Stress (UCS) in Sprague Dawley Rats after Treatment with the Biofield Energy Treated Novel Proprietary Test Formulation
  53. Effects of Consciousness Energy Healing Treatment on the Improvement of Relative Oral Bioavailability of Low Bioavailable Resveratrol in Male Sprague Dawley Rats
  54. The Isotopic Abundance Ratio of Consciousness Energy Treated L-Tryptophan Using LC-MS Spectrometry
  55. Influence of the Biofield Energy Treatment on the Pharmacokinetics of 25-Hydroxyvitamin D3 in Male Sprague-Dawley Rats after a Single Oral Dose of Vitamin D3
  56. The Biofield Energy Treatment and its Effect on the Relative Oral Bioavailability of Lovastatin Hydroxy Acid in Rats after a Single Oral Dose of Lovastatin
  57. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  58. LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of Consciousness Energy Healing Treated Ofloxacin
  59. Analysis of Isotopic Abundance Ratio of Consciousness Energy Healing Treated Metronidazole Using LC-MS and GC-MS Spectrometry
  60. Assessment of Neurobehavioral and Anti-Aging Effect of the Test Formulation in D-Galactose-Induced aging Dysfunction in Sprague Dawley Rats
  61. Prevention of Aging and Improvement of Longevity and Life-Span in D-Galactose Induced Aging Rats After Treatment with the Biofield Energy Per Se and Biofield Treated Proprietary Test Formulation
  62. Gas Chromatography and Mass Spectroscopy (GC-MS) Based Isotopic Abundance Ratio Evaluation of the Biofield Energy Treated Metronidazole
  63. Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
  64. Antiaging, Cognition and Anti-Inflammatory Potential of the Biofield Energy Treatment in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  65. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Cefazolin Sodium Using LC-MS and GC-MS Spectrometry
  66. Improvement of Vitamin D 3 Metabolites Level after Oral Administration of the Biofield Energy Treated Proprietary Test Formulation in Vitamin D 3 Deficiency Diet (VDD) Induced Rat Model
  67. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios (PM+1/PM and PM+2/PM) of Ofloxacin
  68. Influence of Consciousness Energy Healing Treatment on the Properties of Polylactic-co- Glycolic Acid (PLGA)
  69. Characterization of the biofield energy treated aluminium using PSA, PXRD, and TGA/DTG analytical techniques
  70. Consciousness Energy Healing Treatment Influenced the Physicochemical Properties of Zinc
  71. "Evaluation of Physicochemical and Thermal Properties of the Consciousness Energy Healing Treated Tellurium"
  72. In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
  73. Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
  74. Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
  75. Antioxidant and Organ Protective Potential of the Consciousness Energy Healing-Based Novel Test Formulation Using Different Biomarkers Analysis
  76. "Assessment of the Biofield Energy Healing Based Test Formulation on Human Organ Health Specific Biomarkers In Vitro Assays"
  77. Powder X-ray Diffraction and Particle Size Analysis of the Consciousness Energy Healing Treated Vanadium Pentoxide (V2O5)
  78. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Zinc
  79. Consciousness Energy Healing Treatment: Physicochemical and Thermal Characterization of Magnesium
  80. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Properties of Pyridoxine HCl
  81. Complementary and Alternative Medicine: Impact of Consciousness Healing Treatment on the Characteristic Properties of Sulfamethoxazole
  82. Physicochemical and Thermal Characterization of Ascorbic Acid: Impact of Biofield Energy Treatment
  83. Physicochemical and Thermal Characterization of the Consciousness Energy Healing Treated Folic acid
  84. Evaluation of Stress Biomarkers after Oral Administration of the Consciousness Energy Healing Treated Novel Herbomineral Formulation in Male Sprague Dawley Rats
  85. Solid State Characterization of the Consciousness Energy Healing Treated Magnesium
  86. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Cefazolin Sodium
  87. Evaluation of a Consciousness Energy Healing Based Test Formulation for Skin Health
  88. Complementary and Alternative Medicine: Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Treated Metronidazole
  89. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
  90. Evaluation of the Physicochemical and Thermal Properties of Folic Acid: Influence of the Energy of Consciousness Healing Treatment
  91. Evaluation of Estrogenic Activity of Biofield Energy Treatment for the Potential of Menstrual Disorders Using Ishikawa Cell Line
  92. Flutamide: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Characteristics
  93. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine
  94. Spectroscopic and Calorimetric Evaluation of the Biofield Energy Healing Treated Ofloxacin
  95. Effect of the Consciousness Energy Healing Treatment on the Characteristic Properties of Cefazolin Sodium
  96. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Cholecalciferol (Vitamin D3)
  97. Biofield Energy Treatment: Physicochemical and Thermal Characterization of L-Tryptophan
  98. Consciousness Energy Healing Treatment: Spectroscopic and Calorimetric Evaluation of the Biofield Energy Treated Hydroxypropyl β-Cyclodextrin
  99. Anti-Rheumatoid Arthritis (RA) Action of Biofield Energy Treatment Using Synovial Sarcoma Cell Line (SW982)
  100. Assessment of Anti-Ageing Potential of Consciousness Energy Healing Treated DMEM and HFF-1 Cells using Cellular Proliferation and Collagen Metabolism Assays
  101. Characterization of the Physicochemical and Thermal properties of the Biofield Energy Treated Flutamide Using PSA, PXRD, TGA/DTG, and DSC Analytical Techniques
  102. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
  103. Assessment of the Physicochemical and Thermal Characterization of Biofield Energy Treated Polylactic-co-glycolic acid (PLGA)
  104. Complementary and Alternative Medicine: Impact of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Withania somnifera Root Extract
  105. Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
  106. Investigation of Vital Organ Specific Biomarkers Using CellBased Assays after Treatment with the Biofield Energy Treated Test Formulation
  107. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
  108. Evaluation of the Outcome of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium
  109. Impact of the Trivedi Effect® on the Physicochemical Properties of Antimony
  110. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine
  111. Biofield Energy Therapy: Role in Multiple Organ Health Specific Biomarkers in Cell-Based Assay
  112. Physicochemical and Thermal Characterization of Consciousness Energy Healing Treated Copper (II) Chloride Using PXRD, DSC, and TGA/DTG
  113. Powder XRD, PSD and DSC Analysis of the Consciousness Energy Healing Treated Zinc Chloride
  114. Evaluation of the Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  115. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Silver Sulfadiazine
  116. Wound Healing Activity of Consciousness Energy Healing Treatmenton HFF-1 Cells and DMEM Using Scratch Assay
  117. Evaluation of the Consciousness Energy Healing Treated Berberine Chloride Using PXRD, PSA, and DSC Analysis
  118. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of 6-Mercaptopurine
  119. The Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Silver Oxide (Ag2O)a
  120. In Vitro Assessment of Biofield Energy Healing Treatment on Hair Growth by Enhanced Proliferation of Human Follicular Dermal Papilla Cells (HFDPCs)
  121. In vitro Assessment of Biofield Energy Treated DMEM on Thermogenesis Using Myoblasts Cell Line (C2C12)
  122. Assessment of Biofield Energy Treatment on Liver Health Using Hepatocellular Carcinoma Cell Line (HepG2)
  123. Influence of the Biofield Energy Therapy on the Physicochemical and Thermal Properties of Sulfamethoxazole
  124. Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC
  125. Evaluation of the Physicochemical and Thermal Properties of Chromium Trioxide (CrO3): Impact of Consciousness Energy Healing Treatment
  126. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
  127. Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  128. An Investigation of the Consciousness Energy Healing Therapy on Physicochemical and Thermal Properties of Silver Sulfadiazine
  129. Antioxidative Potential of Consciousness Energy Healing Treatment on HepG2 Cells and DMEM after Oxidative Stress Induced by Hydrogen Peroxide
  130. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  131. Effect of the Consciousness Energy Healing Treatment on DMEM for the Proliferation and Differentiation of Human Bone Osteosarcoma Cells to Improve Bone Health
  132. Antiaging Potentia
  133. Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Healing Treated Ofloxacin
  134. Antiaging Potential of Consciousness Energy Healing-Based Novel Proprietary Formulation
  135. Role of Vitamin D3 on Bone Health in Human Bone Osteosarcoma Cells (MG-63): Influence of Biofield Energy Healing Treatment
  136. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Vitamin D3 (Cholecalciferol)
  137. The Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of L-Cysteine
  138. The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of 6-Mercaptopurine
  139. Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  140. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Lead Using PXRD, PSA, and DSC Analysis
  141. Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters
  142. Biofield Energy Treated Vitamin D3 on the Structural Crosslinks, Maturation, and Bone Mineralization
  143. Assessment of Energy of Consciousness Healing on Cell Growth of Plant Stem Cells Callus Culture
  144. "A Comparative Analysis of Vitamin D3 and Biofield Energy Treated Vitamin D3 in Bone Health Using MG-63 Cell Line"
  145. Increase in Bone Mass Density and Overall Bone Health Following High-Impact of Bio-field Energy Treated Vitamin D3inMG-63 Cell Line
  146. Biofield Energy Enriched Vitamin D3 versus Vitamin D3 in Preventing Fractures and Bone Loss
  147. Functional Modification of Bone Tissues After Treatment with the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  148. Role of Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63): A Multidisciplinary Aspect on Bone Health
  149. Vitamin D3 and Consciousness Energy Healing TreatmentModality on Human Osteoblast Cells
  150. The Bone Regenerative Effects of the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  151. Biofield Energy Healing Based Vitamin D3: An Improved Overall Bone Health Activity in MG-63 Cell Line
  152. Influence of the Biofield Energy Treated Vitamin D<sub>3</sub> on Human Osteoblast-Like Cells
  153. Effect of Biofield EnergyTreated Vitamin D3 on the Proliferation of Osteoblast-Like MG-63 Human Osteosarcoma Cells in vitro
  154. Biofield Energy Based Vitamin D<sub>3</sub> Stimulates <i>In vitro</i> Osteoblasts Differentiation in MG-63 Cell line
  155. An <i>In vitro</i> Experiment on Bone Growth and Differentiation in Human Bone Osteosarcoma Cells (MG-63): Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  156. Assessment of Bone Health After Treatment with the Consciousness Energy Healing Treated Vitamin D<sub>3</sub> in Human Bone Osteosarcoma Cells (MG-63)
  157. Biofield Energy Enriched Vitamin D<sub>3</sub>: A New Horizons for Development of Bone Health Using MG-63 Cells
  158. Regulation of Bone Health Parameters After Treatment with Biofield Energy Healing Based Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63)
  159. <i>In vitro</i> Study on Human Bone Osteosarcoma Cells (MG-63): Role of Biofield Energy Treated Vitamin D<sub>3</sub>
  160. Biofield Energy Treated Vitamin D<sub>3</sub>: Therapeutic Implication on Bone Health Using Osteoblasts Cells
  161. The Influence of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health and Its Health Consequences in MG-63 Cell-Line
  162. Effect of Biofield Energized Vitamin D<sub>3</sub> on Bone Health in MG-63 Cell-Line
  163. Regulation of Bone Health Parameters in MG-63 Cell Line After Treatment with Biofield Energy Treated Vitamin D<sub>3</sub>
  164. The Effect of Vitamin D<sub>3</sub> on Bone Mineralization: Influence of Consciousness Energy Healing Treatment
  165. Evaluation of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health Parameters in Human Bone Osteosarcoma Cells (MG-63)
  166. Influence of Biofield Treated Vitamin D<sub>3</sub> on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line
  167. A Perspective of Bone Health Study: Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  168. Influenced of Biofield Energy Healing Treatment on Vitamin D<sub>3</sub> for the Assessment of Bone Health Parameters in MG-63 cells
  169. Evaluation of Biofield Energy Treated Vitamin D<sup>3</sup> in Human Osteoblasts Cells
  170. Exploring the Effects of Biofield Energy Treated Vitamin D<sup>3</sup> on Bone Health Parameters in MG-63 Cell Line
  171. The Potential Benefits of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Mineralization in Human Bone Osteosarcoma Cells (MG-63)
  172. Improved Metabolism of Vitamin D<sub>3</sub> in Human Osteoblasts Cells After Biofield Energy Healing Treatment
  173. An Alternative Approach for the Management of Bone Health: Role of Biofield Energy Healing Treated Vitamin D<sub>3</sub>
  174. Effects of Vitamin D<sub>3</sub> on the Proliferation and Mineralization of Human Osteoblast-Like Cells: Implications of Biofield Energy Healing Treatment
  175. Impact of Biofield Energy Healing Treated Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63) for Bone Health
  176. Role of Vitamin D<sub>3</sub> on Alkaline Phosphatase, Collagen, and Bone Mineralization: Impact of Biofield Energy Healing Treatment
  177. Biofield Energy Treated Vitamin D<sub>3</sub>: Direct Effect on Bone Health Using Human Osteoblast-Like Cells
  178. <i>In Vitro</i> Effects of Biofield Energy Treated Vitamin D<sub>3</sub> Supplementation on Bone Formation by Osteoblasts Cells
  179. Energy of Consciousness Healing on Growth and Yield of the Plant Stem Cells Culture
  180. Evaluation of the Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of Flutamide
  181. Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole
  182. Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Hydroxypropyl -Cyclodextrin
  183. Evaluation of the Effect ofBiofield Energy Treatment on Physicochemical and Thermal Properties of Hydroxypropyl β-Cyclodextrin
  184. Effect of Biofield Energy Treatment on Bone Cell Proliferation and Differentiation for the Assessment of its Potential to Improve Bone Health
  185. Physicochemical and Spectroscopic Characterization of Biofield TreatedButylated Hydroxytoluene
  186. Effect of Biofield Energy Treated Cell Growth Medium on Human Fibroblast Cell Growth for Assessment of Skin Health Promotion Potential
  187. Evaluation of Bone Mineral Density and Biochemical Parameters of Bone Metabolism after Treatment with Biofield Energy Treated Vitamin D3 in MG-63 Cells
  188. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
  189. Spectral, and Thermal Properties of Sodium Selenate Treated with the Energy of Consciousness
  190. Consciousness Healing Treatment on the Physical, Structural, and Thermal Properties of Zinc Chloride
  191. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  192. Energy Healing Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride
  193. Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  194. Structure and Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  195. Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness
  196. Properties of Sodium Selenate Treated with the Energy of Consciousness (The Trivedi Effect®)
  197. Properties and Isotopic Abundance Ratio of Biofield Energy Treated Magnesium Gluconate
  198. Evaluation of Isotopic Abundance Ratio and Structural Properties of Magnesium Gluconate
  199. Evaluation of Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  200. Evaluation of the Energy of Consciousness Healing Treated Withania somnifera Root Extract
  201. Magnesium Gluconate Treated with the Energy of Consciousness Using LC-MS and NMR Spectroscopy
  202. Withania Somnifera (Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy
  203. Physical, Spectroscopic, Thermal and Behavioral Properties of Ashwagandha Root Extract
  204. Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  205. Consciousness Energy Healing Treatment on Withania somnifera Root Extract
  206. Evaluation of the Physicochemical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  207. Evaluation of Skin Protective Effect Using in Vitro Cell Line Models of Biofield
  208. Skin Nourishing Effects of Biofield Energy Healing Treatment Based Herbomineral Formulation
  209. Skin Protective Activity of Consciousness Energy Healing Treatment Based Herbomineral Formulation
  210. The Study of Biofield Energy Treatment Based Herbomineral Formulation in Skin Health and Function
  211. Use of Consciousness Energy Healing Based Herbomineral Formulation for Skin Anti-Aging Strategies
  212. Overall Skin Health Potential of the Biofield Energy Healing Based Herbomineral Formulation
  213. Energy Healing Treatment on Herbomineral Formulation in Different Skin Health Parameters
  214. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
  215. Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate
  216. Physicochemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  217. Structural Characterization and Isotopic Abundance Ratio Analysis of Magnesium Gluconate
  218. Healing Treatment on Physical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  219. Consciousness Healing Treated Withania Somnifera Root Extract Using LC-MS, GC-MS, and NMR
  220. Withania somnifera Root Extract Using GC-MS and Nuclear Magnetic Resonance Spectroscopy
  221. Physicochemical, Thermal, Structural, and Behavioral Properties Analysis in Magnesium Gluconate
  222. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  223. Solid State Characterization of Withania somnifera (Ashwagandha) Root Extract
  224. Energy Healing Treatment Based Herbomineral Formulation Against Various Skin Health Parameters
  225. Skin Photo-Protective and Anti-ageing Activity of Consciousness Energy Healing Treatment
  226. An in Vitro Study of Biofield Energy Healing Based Herbomineral Formulation for Skin Protection
  227. Immunomodulatory Response of Herbomineral Formulation in Male Sprague Dawley Rats
  228. Novel Herbomineral Formulation After Oral Administration in Male Sprague Dawley Rats
  229. Characterization of the Consciousness Energy Healing Treated Withania somnifera Root Extract
  230. Analysis of Withania somnifera Root Extract After Treatment with the Energy of Consciousness
  231. Differential Regulation of Immune Biomarkers by the The Trivedi Effect® on Herbomineral Formulation
  232. Immunopotentiating Impact of The Trivedi Effect® on Herbomineral Formulation Oral Administration
  233. Evaluation of the Physico-chemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  234. Impact of Trivedi Effect® on Physicochemical, Thermal, Properties of Magnesium Gluconate
  235. Evaluation of Immunomodulatory Properties After Oral Administration of Biofield Energy Treated Test Formulation in <i>Sprague Dawley</i> Rats: Influence of the Trivedi Effect<sup>®</sup>
  236. Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation on Various Biomarkers in Male <i>Sprague Dawley</i> Rats: Potential Role of the Trivedi Effect<sup>®</sup>
  237. Characterization of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate After Treatment with the Energy of Consciousness
  238. Evaluation of Immune Biomarkers After Oral Administration of the Novel Herbomineral Formulation Treated with The Trivedi Effect<sup>®</sup> - Biofield Energy Healing in Male <i>Sprague Dawley</i> Rats
  239. Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in <i>Sprague Dawley</i> Rats: Evidence for Humoral and Cell-Mediated Responses
  240. An Investigation of The Trivedi Effect<sup>®</sup>-Energy of Consciousness Healing Treatment to Modulate the Immunomodulatory Effect of Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  241. Assessment of Consciousness Energy Healing Treatment on Immune Biomarkers After Oral Administration of Herbomineral Formulation in <i>Sprague Dawley</i> Male Rats
  242. Evaluation of Immune Biomarkers After Oral Administration of Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  243. Evaluation of Immunomodulatory Parameters in Female <i>Sprague Dawley</i> Rats after Oral Administration of the Biofield Energy Healing Treated Herbomineral Formulation
  244. Impact of Biofield Treated Formulation on Immune Biomarkers of Female Sprague Dawley Rats
  245. Investigation of Immune Biomarkers Regulation by Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  246. Modulation of Immune Biomarkers by Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rat: Potential Role of Energy of Consciousness
  247. Effect of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation on Immune Biomarkers After Oral Administration in Female <i>Sprague Dawley</i> Rats
  248. Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment
  249. Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female <i>Sprague Dawley</i> Rats
  250. Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment
  251. Implication of Biofield Energy Healing Based Vitamin D3 on Osteoblastic Differentiation
  252. Improved Bone Health Parameters After Treatment with Consciousness Energy Treated Vitamin D3
  253. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Treated Ortho-Toluic Acid
  254. Biochemical Reactions, and Genotypic Pattern of Biofield Treated Pseudomonas aeruginosa
  255. Thermal, Spectroscopic and Chemical Characterization of Biofield Energy Treated Anisole
  256. Biofield Energy Treated Nitrophenol Derivatives Using Gas Chromatography-Mass Spectrometry
  257. Physicochemical Characterization of Biofield Energy Treated Hi VegTM Acid Hydrolysate
  258. 1,2,3-Trimethoxybenzene (TMB) After Biofield Energy Treatment (The Trivedi Effect®) Using GC-MS
  259. Biofield Energy Treated Resorcinol Using Gas Chromatography-Mass Spectrometry Technique
  260. Isotopic Abundance of 2H, 13C, 18O, and 37Cl in Biofield Energy Treated Dichlorophenol Isomers
  261. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Indole Using GC-MS
  262. 13C/12C or 2H/1H and 18O/16O in Biofield Energy Treated 1-Chloro-3-Nitrobenzene (3-CNB) Using GC-MS
  263. Isotopic Abundance of 13C, 2H, and 18O in Biofield Energy Treated p-tertiary Butylphenol (PTBP)
  264. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin)
  265. Biofield Energy Treated 1,4-Dichlorobenzene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  266. Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation in Mouse Splenocytes
  267. Evaluation Mouse Splenocytes After Co-Incubation with the Biofield Energy Treated Formulation
  268. Mouse Splenocyte Cells After Incubation with Biofield Energy Healing Based Herbomineral Formulation
  269. Impact of the Trivedi Effect Herbomineral Formulation on Pro-inflammatory Cytokines Expression
  270. Pro-Inflammatory Cytokines Expression in Murine Dendritic and Splenocyte Cells
  271. Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation
  272. Mouse Dendritic and Splenocyte Cells for Modulation of Pro-inflammatory Cytokines
  273. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Ammonium Acetate and Ammonium Chloride: An Impact of Biofield Treatment
  274. Characterization of Physical, Thermal and Structural Properties of Chromium (VI) Oxide Powder: Impact of Biofield Treatment
  275. Characterization of Physical, Spectral and Thermal Properties of Biofield Treated 1,2,4-Triazole
  276. Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae after Biofield Treatment
  277. Physical, Thermal and Spectroscopic Characterization of m-Toluic Acid: an Impact of Biofield Treatment
  278. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Biofield Treated Salicylic Acid and Sparfloxacin
  279. Physical and Structural Characterization of Biofield Treated Imidazole Derivatives
  280. Evaluation of Physical, Thermal and Spectroscopic Properties of Biofield Treated p-Hydroxyacetophenone
  281. Characterization of Physico-Chemical and Spectroscopic Properties of Biofield Energy Treated 4-Bromoacetophenone
  282. Physicochemical and Spectroscopic Characterization of Biofield Treated Triphenyl Phosphate
  283. Physical and Structural Characterization of Biofield Energy Treated Carbazole
  284. Evaluation of Biofield Treatment on Atomic and Thermal Properties of Ethanol
  285. Characterisation of Physical, Spectral and Thermal Properties of Biofield treated Resorcinol
  286. Physicochemical and Atomic Characterization of Silver Powder after Biofield Treatment
  287. Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium Nitrate after Biofield Treatment
  288. Characterization of Physical and Structural Properties of Aluminium Carbide Powder: Impact of Biofield Treatment
  289. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen
  290. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Methyl-2-Naphthyl Ether
  291. Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment
  292. Physical, Thermal and Spectral Properties of Biofield Treated 1,2,3-Trimethoxybenzene
  293. Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen
  294. Physical, Thermal and Spectroscopic Characterization of Biofield Treated p-Chloro-m-cresoln
  295. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine
  296. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated O-Aminophenol
  297. Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate after Biofield Treatment
  298. Biofield Energy Treatment: A Potential Strategy for Modulating Physical, Thermal and Spectral Properties of 3-Chloro-4-fluoroaniline
  299. The Potential Impact of Biofield Energy Treatment on the Physical and Thermal Properties of Silver Oxide Powder
  300. Physical and Thermal Properties of O-Nitrophenol, M-Nitrophenol and P-Tertiary Butyl Phenol
  301. Antibiogram Pattern of Shigella flexneri: Effect of BioField Treatment
  302. Physical, Thermal and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone
  303. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Energy Treated p-Phenylenediamine and p-Toluidine
  304. Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes
  305. Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis
  306. Potential Impact of BioField Treatment on Atomic and Physical Characteristics of Magnesium
  307. Evaluation of Thermal and Physical Properties of Magnesium Nitride Powder: Impact of Biofield Energy Treatment
  308. Influence of Biofield Treatment on Physical and Structural Characteristics of Barium Oxide and Zinc Sulfide
  309. Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on Morganella morganii
  310. Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates
  311. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  312. Assessment of Antibiogram of Multidrug-Resistant Isolates of Enterobacter aerogenes after Biofield Energy Treatment
  313. Characterization of Biofield Energy Treated 3-Chloronitrobenzene: Physical, Thermal, and Spectroscopic Studies
  314. Impact of Biofield Energy Treatment on Soil Fertility
  315. Influence of Biofield Energy Treatment on Isotopic Abundance Ratio in Aniline Derivatives
  316. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
  317. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Potato Micropropagation Medium
  318. Evaluation of Biofield Treated Peptone And Malmgren Modified Terrestrial Orchid Medium
  319. Physical, Thermal and Spectral Properties of Biofield Treated 3-Nitroacetophenone
  320. Thermal, Spectroscopic and Chromatographic Characterization of Biofield Energy Treated Benzophenone
  321. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2-Aminopyridine
  322. Characterization of Physical, Spectroscopic and Thermal Properties of Biofield Treated Biphenyl
  323. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2,6-Dichlorophenol
  324. Physicochemical and Spectral Characterization of Biofield Energy Treated 4-Methylbenzoic Acid
  325. Chromatographic, Spectroscopic, and Thermal Characterization of Biofield Energy Treated N,N-Dimethylformamide
  326. Physicochemical Characterization of Biofield Energy Treated Calcium Carbonate Powder
  327. Molecular Analysis of Biofield Treated Eggplant and Watermelon Crops
  328. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated p-Anisidine
  329. Characterization of Physical and Thermal Properties of Biofield Treated Neopentyl glycol
  330. Physical, Thermal and Spectral Parameters of Biofield Energy Treated Methylsulfonylmethane
  331. Antibiogram Typing of Biofield Treated Multidrug Resistant Strains of Staphylococcus Species
  332. Analysis of Physical, Thermal, and Structural Properties of Biofield Energy Treated Molybdenum Dioxide
  333. Physical and Structural Properties of Calcium Carbide and Praseodymium Oxide
  334. Physicochemical and Spectroscopic Characteristics of Biofield Treated p-Chlorobenzophenone
  335. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated Date Palm Callus Initiation Medium
  336. Biofield Energy Treatment on Physical and Thermal Characteristics of Selenium Powder
  337. Morphological Characterization, Quality, Yield & DNA Fingerprinting of Energy Treated Alphonso Mango
  338. Escherichia coli for Antimicrobial Susceptibility, Biochemical Reaction and Biotyping
  339. Evaluation of Isotopic Abundance Ratio in Naphthalene Derivatives After Biofield Energy Treatment
  340. Improved Susceptibility Pattern of Antimicrobials Using Vital Energy Treatment on Shigella sonnei
  341. Biochemical Differentiation & Molecular Characterization of Biofield Treated Vibrio parahaemolyticus
  342. Physical, Thermal and Spectroscopical Characterization of Biofield Treated Triphenylmethane: An Impact of Biofield Treatment
  343. Experimental Investigation on Physical, Thermal and Spectroscopic Properties of 2-Chlorobenzonitrile: Impact of Biofield Treatment
  344. Characterization of Biofield Energy Treated Murashige and Skoog Plant Cell Culture Media
  345. Physicochemical and Spectroscopic Characterization of Yeast Extract Powder After the Biofield Energy Treatment
  346. Physical, Spectroscopic and Thermal Characterization of Biofield Treated Fish Peptone
  347. Physicochemical and Spectroscopic Properties of Biofield Energy Treated Protose
  348. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated Gerbera Multiplication Medium
  349. Biofield Treated Phosphate Buffer Saline and Hanks Balanced Salt Medium
  350. Characterization of Physicochemical and Spectroscopic Properties of Biofield Energy Treated Bio Peptone
  351. Spectral and Thermal Properties of Biofield Energy Treated Cotton
  352. Effect of Biofield Treated Energized Water on the Growth and Health Status in Chicken
  353. Characterization of Atomic and Physical Properties of Biofield Energy Treated Manganese Sulfide Powder
  354. Assessment of Antibiogram of Biofield Energy Treated Serratia marcescens
  355. Biofield Treatment on Viral Load Against Human Immunodeficiency-1 and Cytomegalo Viruses
  356. Antibiogram, Biochemical Reactions and Biotyping of Biofield Treated Providencia rettgeri
  357. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using GC-MS
  358. Phenotyping and Genotyping Characterization of Proteus vulgaris After Biofield Treatment
  359. Plant Growth Regulator, Immunity and DNA Fingerprinting of Biofield Energy Treated Mustard Seeds
  360. Agronomic Characteristics, Growth Analysis, and Yield Response of Biofield Treated Mustard, Cowpea, Horse Gram, and Groundnuts
  361. Physical, Thermal and Spectroscopic Studies of Biofield Treated p-Chlorobenzonitrile
  362. Effect of Biofield Treatment on Physical, Thermal, and Spectral Properties of SFRE 199-1 Mammalian Cell Culture Medium
  363. Biochemical Marker – Glutathione and DNA Fingerprinting of Biofield Energy Treated Oryza sativa
  364. Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections
  365. Morphological and Molecular Analysis Using RAPD in Biofield Treated Sponge and Bitter Gourd
  366. Antibiogram, Biochemical Reactions and Genotyping Characterization of Biofield Treated <i>Staphylococcus aureus</i>
  367. Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
  368. Vegetative Growth Parameters in Biofield Treated Bottle Gourd (Lagenaria siceraria) & Okra
  369. Genetic Diversity Using SSR Markers & Growth Regulator Response in Biofield Treated Cotton
  370. Ratio of 13C, 2H, and 18O in Biofield Energy Treated Ortho and Meta Toluic Acid Isomers
  371. Plant Growth, Yield and Yield Attributes of Biofield Energy Treated Mustard and Chick Pea Seeds
  372. Antimicrobial Susceptibility of Proteus mirabilis: Impact of Biofield Energy Treatment
  373. Bacterial Identification Using 16S rDNA Gene Sequencing and Antibiogram Analysis on Biofield Treated Pseudomonas fluorescens
  374. Impact of Biofield Treatment on Spectroscopic and Physicochemical Properties of p-Nitroaniline
  375. Physicochemical and Spectroscopic Characterization of p-Chlorobenzaldehyde: An Impact of Biofield Energy Treatment
  376. Evaluation of Atomic, Physical and Thermal Properties of Tellurium Powder: Impact of Biofield Energy Treatment
  377. Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
  378. Characterization of Antimicrobial Susceptibility Profile of Biofield Treated Multidrug-resistant Klebsiella oxytoca
  379. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii
  380. Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae
  381. Modification of Physical and Thermal Properties of Gluten Hydrolysate and Ipomoea Macroelements
  382. Investigation of Isotopic Abundance Ratio of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry
  383. Physical, Atomic and Thermal Properties of Biofield Treated Lithium Powder
  384. Potential Impact of Biofield Energy Treatment on the Atomic, Physical and Thermal Properties Indium Powder
  385. Physical, Spectroscopic and Thermal Characterization of Biofield treated Myristic acid
  386. Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichlorobenzene
  387. Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotyping of Salmonella paratyphi A: An Impact of Biofield Treatment
  388. Spectroscopic Characterization of Disulfiram and Nicotinic Acid after Biofield Treatment
  389. Biofield Treatment: A Potential Strategy for Modification of Physical and Thermal Properties of Indole
  390. In Vitro Evaluation of Antifungal Sensitivity Assay of Biofield Energy Treated Fungi